Twenty-one patients were immunocompromised at the time of TB diagnosis (9 had HIV, 11 were treated with anti-TNFα, and 1 with mycophenolate mofetil), whereas 24 (53%) were immunocompetent. This evidence concerns the gene TNF and tuberculosis.